{{Rsnum
|rsid=9679290
|Gene=EPAS1
|Chromosome=2
|position=46330505
|Orientation=plus
|GMAF=0.4656
|Gene_s=EPAS1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 22.1 | 54.0 | 23.9
| HCB | 45.3 | 46.0 | 8.8
| JPT | 39.8 | 44.2 | 15.9
| YRI | 4.8 | 30.6 | 64.6
| ASW | 3.5 | 38.6 | 57.9
| CHB | 45.3 | 46.0 | 8.8
| CHD | 45.9 | 46.8 | 7.3
| GIH | 8.9 | 46.5 | 44.6
| LWK | 3.6 | 30.9 | 65.5
| MEX | 43.1 | 50.0 | 6.9
| MKK | 5.1 | 39.7 | 55.1
| TSI | 12.7 | 46.1 | 41.2
| HapMapRevision=28
}}{{PMID Auto
|PMID=22113997
|Title=The chromosome 2p21 region harbors a complex genetic architecture for association with risk for renal cell carcinoma
|OA=1
}}

{{on chip | Affy GenomeWide 6}}